Revenue - HitGen Inc (SSE:688222) - Alpha Spread

HitGen Inc
SSE:688222

Watchlist Manager
HitGen Inc Logo
HitGen Inc
SSE:688222
Watchlist
Price: 8.47 CNY -1.05% Market Closed
Market Cap: 3.4B CNY
Have any thoughts about
HitGen Inc?
Write Note

HitGen Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HitGen Inc
Revenue Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
HitGen Inc
SSE:688222
Revenue
ÂĄ371.3m
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Revenue
ÂĄ38.7B
CAGR 3-Years
25%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Revenue
ÂĄ11.5B
CAGR 3-Years
23%
CAGR 5-Years
29%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Revenue
ÂĄ17.1B
CAGR 3-Years
28%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Revenue
ÂĄ7B
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
33%
Genscript Biotech Corp
HKEX:1548
Revenue
$1B
CAGR 3-Years
31%
CAGR 5-Years
33%
CAGR 10-Years
N/A

See Also

What is HitGen Inc's Revenue?
Revenue
371.3m CNY

Based on the financial report for Dec 31, 2023, HitGen Inc's Revenue amounts to 371.3m CNY.

What is HitGen Inc's Revenue growth rate?
Revenue CAGR 5Y
20%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for HitGen Inc have been 15% over the past three years , 20% over the past five years .

Back to Top